Software can be installed and ready to go within as little as an hour, in a move to keep a ‘digital eye’ over the ever-increasing number of COVID-19 patients
Using a substrain of E. coli MG 1655 and nanoscale red blood cell membranes, researchers created tiny biohybrid swimmers that could personalize drug delivery to treat tumors